When it comes to the biggest investors in Research and Development (R&D) Swiss pharma top dogs Novartis and Roche have defended their positioning among the top ten companies worldwide – according to a recently published EU study.
{iframe}http://www.european-biotechnology-news.com/news/news/2014-04/novartis-and-roche-leaders-in-rd.html{/iframe}